Suliat Oyelami-Davies
Associate Director, Clinical Operations at Eidos Therapeutics - San Francisco, CA, US
Suliat Oyelami-Davies's Colleagues at Eidos Therapeutics
Suliat Oyelami-Davies's Contact Details
HQ
415-887-1471
415-887-1471
Location
Company
Eidos Therapeutics
Eidos Therapeutics
Suliat Oyelami-Davies's Company Details
Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company's singular mission is to improve and prolong the lives of patients suffering from this disease.Launched in 2016 after years of research supported by Stanford's SPARK program, Eidos is led by a team of veteran biotechnology executives. Together with patients and physicians, the company aims to bring a safe, effective treatment to market as quickly as possible.
Frequently Asked Questions about Suliat Oyelami-Davies
Suliat Oyelami-Davies currently works for Eidos Therapeutics.
Suliat Oyelami-Davies's role at Eidos Therapeutics is Associate Director, Clinical Operations.
Suliat Oyelami-Davies's email address is ***@eidostx.com. To view Suliat Oyelami-Davies's full email address, please signup to ConnectPlex.
Suliat Oyelami-Davies works in the Research industry.
Suliat Oyelami-Davies's colleagues at Eidos Therapeutics are Sunil Erraballi, Paul Wong, Suresh Siddhanti, Suliat Mshs, Suliat Davies, Maria Albaira, Dawne Hom and others.
Suliat Oyelami-Davies's phone number is 415-887-1471